Concepedia

Publication | Open Access

A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer

26

Citations

33

References

2021

Year

Abstract

We developed the MRSB, an eight-gene-based methylation signature, which has great potential to be used to predict the post-surgery progression risk of BLCA.

References

YearCitations

Page 1